Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Phase Ib: To estimate the MTD and/or RP2D of MEK162 in combination with panitumumab Phase II: To assess clinical efficacy of the MEK162 and panitumumab combination
Inclusion criteria
- Mutant RAS or wild-type (WT) RAS metastatic colorectal cancer